Rivernorth Capital Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100,000
Closed -$1.03M 510
2025
Q3
$1.03M Sell
100,000
-400,000
-80% -$4.17M 0.06% 244
2025
Q2
$5.14M Hold
500,000
0.28% 99
2025
Q1
$5.07M Hold
500,000
0.27% 92
2024
Q4
$5.01M Buy
+500,000
New +$5.01M 0.24% 93

Other funds holding TDACU

Rivernorth Capital Management's TDACU Position: Q4 2025 in Review

Rivernorth Capital Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q4 2025, closing a stake of 100,000 shares — an estimated $1.03M sold.

Rivernorth Capital Management first reported a position in TDACU in Q4 2024 and held it in 4 quarters. The position peaked at $5.14M in Q2 2025. 5 funds tracked by Wall St. Rank hold TDACU as of Q4 2025.

  • Rivernorth Capital Management reported no remaining Translational Development Acquisition Corp Units position as of Q4 2025 after selling out during the quarter.
  • Rivernorth Capital Management sold 100,000 Translational Development Acquisition Corp Units shares in Q4 2025, an estimated $1.03M.
  • Rivernorth Capital Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 4 quarters.
  • Rivernorth Capital Management's Translational Development Acquisition Corp Units position peaked at $5.14M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q4 2025.

Based on Rivernorth Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.